Nicole C. Lorona

Nicole C. Lorona

Auto-generated profile, based on publicly available information

Nicole C. Lorona

Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2021 in Breast Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
NLNicole C. Lorona
Nicole C. Lorona
KMKathleen E. Malone
Kathleen E. Malone
CLChristopher I. Li
Christopher I. Li
Purpose Previous research has found significant survival disparities between Black and White women among select stages and subtypes of breast cancer, however other racial/ethnic groups have been less well-studied. This study expands on previous research, examining differences in breast cancer-specific mortality across multiple racial and ethnic groups. Methods Women diagnosed with a first primary invasive breast cancer between 2010 and 2016 who were 20–85 years of age at diagnosis were identified from 18 Surveillance, Epidemiology, and End Results (SEER) registries. Subtypes were defined by joint hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status. Cox proportional hazards models for each stage and subtype were fit, with non-Hispanic white women as the reference group. Effect modification by age at diagnosis (< 50, ≥ 50) was found and thus analyses were age-stratified. Results After multivariable adjustment, younger Black women had greater risks of breast cancer-specific death for all stages of HR+/HER2−, and certain stages of HR+/HER2+ , TN, and HR−/HER2 + breast cancer. Asian/Pacific Islander women generally had a lower hazard of breast cancer-specific death. Older Hispanic White women had a lower hazard of breast cancer-specific death for stages I-III HR + /HER2− and stage II TN breast cancer. Conclusions These findings demonstrate that different racial/ethnic groups experience different risks of breast cancer-specific mortality by stage and subtype. Efforts to address survival disparities should place additional focus on young Black women, as they experience meaningful disparities in breast cancer-specific mortality.

24 March 2025 in Cancer Research
Verified
Journal Article
Closed access
MMMarco Matejcic
Marco Matejcic
JTJamie K. Teer
Jamie K. Teer
HHHannah J. Hoehn
Hannah J. Hoehn
DDDiana B. Diaz
Diana B. Diaz
KSKritika Shankar
Kritika Shankar
SSStephanie L. Schmit
Stephanie L. Schmit
Admixed populations, including the Hispanic/Latino/a community, are underrepresented in cancer genetic/genomic studies. Leveraging the Latino Colorectal Cancer Consortium (LC3) and other existing datasets, we analyzed whole-exome sequencing data on tumor/normal pairs from 718 individuals with colorectal cancer to map somatic mutational features by ethnicity and genetic similarity. Global proportions of African, Asian, European, and Native American genetic ancestries were estimated using ADMIXTURE. Associations between these proportions and somatic mutational features were examined using logistic regression. APC, TP53, and KRAS were the top three mutated genes across all participants and in the subset of Latino individuals in LC3. In analyses examining recurrently mutated genes, tumors from patients of Latino ethnicity had fewer KRAS and PIK3CA mutations compared with tumors from non-Latino patients. Genetic ancestry overall was associated with CDC27 mutation status, and African genetic ancestry was associated with SMAD2 mutation status. In exome-wide analyses, African genetic ancestry was significantly associated with higher odds of mutation in KNCN and TMEM184B. Native American genetic ancestry was associated with a lower frequency of microsatellite instability–high tumors. The SBS11 mutational signature was associated with Native American genetic ancestry as well as Latino ethnicity. In an independent replication dataset, MSK-IMPACT, estimates of association were largely consistent in direction but nonsignificant. A meta-analysis of LC3 and MSK-IMPACT showed that African genetic ancestry was significantly associated with KRAS mutation status and MSI status. This work facilitates precision medicine initiatives by providing insights into the contribution of genetic ancestry to molecular features of colorectal tumors. Significance: Analysis of tumors from various populations can broadly characterize genomic landscapes and enhance precision medicine strategies.

15 April 2019 in Discover Oncology
Verified
Journal Article
Closed access
PDF file
NLNicole C. Lorona
Nicole C. Lorona
LCLinda S. Cook
Linda S. Cook
MTMei-Tzu C. Tang
Mei-Tzu C. Tang
DHDeirdre A. Hill
Deirdre A. Hill
CWCharles L. Wiggins
Charles L. Wiggins
CLChristopher I. Li
Christopher I. Li

4 August 2021 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
NLNicole C. Lorona
Nicole C. Lorona
LCLinda S. Cook
Linda S. Cook
MTMei-Tzu C. Tang
Mei-Tzu C. Tang
DHDeirdre A. Hill
Deirdre A. Hill
CWCharles L. Wiggins
Charles L. Wiggins
CLChristopher I. Li
Christopher I. Li

29 November 2023 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
NLNicole C. Loroña
Nicole C. Loroña
MOMegan Othus
Megan Othus
KMKathleen E. Malone
Kathleen E. Malone
HLHannah M. Linden
Hannah M. Linden
MTMei-Tzu C. Tang
Mei-Tzu C. Tang
CLChristopher I. Li
Christopher I. Li
Background: This study evaluates the relationship between smoking, alcohol, and breast cancer outcomes according to molecular subtype. Methods: This population-based prospective cohort consisted of 3,876 women ages 20 to 69 diagnosed with a first primary invasive breast cancer from 2004 to 2015 in the Seattle–Puget Sound region. Breast cancer was categorized into three subtypes based on estrogen receptor (ER), progesterone receptor (PR), and HER2 expressions: luminal (ER+), triple-negative (TN; ER−/PR−/HER2−), and HER2-overexpressing (H2E; ER−/HER2+). We fit Cox proportional hazards models to assess the association between alcohol consumption and smoking status at diagnosis and risks of recurrence, breast cancer–specific mortality, and all-cause mortality. Results: Histories of ever smoking [HR, 1.33; 95% confidence interval (CI), 1.01–1.74] and current smoking (HR, 1.59; 95% CI, 1.07–2.35) were associated with greater risk of breast cancer recurrence among TN cases. Smoking was also associated with greater risk of recurrence to bone among all cases and among luminal cases. Elevated risks of breast cancer–specific and all-cause mortality were observed among current smokers across all subtypes. Alcohol use was not positively associated with risk of recurrence or mortality overall; however, TN patients who drank four or more drinks per week had a decreased risk of recurrence (HR, 0.71; 95% CI, 0.51–0.98) and breast cancer–specific mortality (HR, 0.73; 95% CI, 0.55–0.97) compared with non-current drinkers. Conclusions: Patients with breast cancer with a history of smoking at diagnosis have elevated risks of recurrence and mortality. Impact: These findings underscore the need to prioritize smoking cessation among women diagnosed with breast cancer.

7 October 2024 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
NLNicole C. Loroña
Nicole C. Loroña
CHCaroline Himbert
Caroline Himbert
JOJennifer Ose
Jennifer Ose
SCStacey Cohen
Stacey Cohen
Ildiko StrehliIldiko Strehli
Ildiko Strehli
CLChristopher I. Li
Christopher I. Li
Background: Findings from studies investigating the impacts of alcohol use and smoking on colorectal cancer outcomes are inconclusive. This study aimed to investigate associations between alcohol use and smoking status at the time of diagnosis on recurrence and overall mortality among patients with colorectal cancer. Methods: The present study included 2,216 stage I–IV patients with colorectal cancer from the longitudinal multicenter ColoCare Study, with available data on recurrence and colorectal cancer–specific mortality. Cox proportional hazards models adjusted for age, sex, race, ethnicity, stage, tumor site, treatment, comorbidities, body mass index, and study site were fit, with imputations for missing data. Results: We observed 235 recurrences and 308 colorectal cancer–specific deaths over an average of 3 years of follow-up. After adjusting for confounders, current alcohol consumption and ever smoking, relative to not current consumption and never smoking, respectively, were not statistically significantly associated with colorectal cancer recurrence [alcohol—HR, 0.95. 95% confidence interval (CI), 0.71–1.29; ever smoking—HR, 0.98, 95% CI, 0.75–1.29] or colorectal cancer–specific mortality (alcohol—HR, 0.95. 95% CI, 0.74–1.22; ever smoking—HR, 0.98, 95% CI, 0.77–1.24). Conclusions: No associations were observed between alcohol and smoking at diagnosis and clinical outcomes in this well-annotated longitudinal cohort. Impact: Our cohort study reports no significant associations; however, limiting alcohol use and avoiding smoking are health behaviors recommended for colorectal cancer survivors for prevention of other cancers and chronic conditions.